Emergent BioSolutions, Inc. (EBS)
10.96
+0.01
(+0.09%)
USD |
NYSE |
Feb 24, 16:00
10.96
0.00 (0.00%)
After-Hours: 20:00
Emergent BioSolutions Price to Book Value : 0.9882 for Feb. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Boston Scientific Corp. | 4.601 |
| Eli Lilly & Co. | 37.06 |
| Penumbra, Inc. | 9.804 |
| Disc Medicine, Inc. | 4.364 |
| MetaVia, Inc. | 6.379 |
Price to Book Value Related Metrics
| PE Ratio | 8.470 |
| PS Ratio | 0.7717 |
| Price to Free Cash Flow | 434.88 |
| Price | 10.96 |
| Earnings Yield | 11.81% |
| Market Cap | 575.62M |
| Operating PE Ratio | 5.248 |
| Normalized PE Ratio | 8.681 |